Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Neuroone Medical Technologies (NMTC) Return on Sales (2020 - 2025)

Historic Return on Sales for Neuroone Medical Technologies (NMTC) over the last 11 years, with Q4 2025 value amounting to 0.5%.

  • Neuroone Medical Technologies' Return on Sales fell 10400.0% to 0.5% in Q4 2025 from the same period last year, while for Dec 2025 it was 0.78%, marking a year-over-year increase of 4700.0%. This contributed to the annual value of 0.4% for FY2025, which is 31700.0% up from last year.
  • Per Neuroone Medical Technologies' latest filing, its Return on Sales stood at 0.5% for Q4 2025, which was down 10400.0% from 0.59% recorded in Q3 2025.
  • Neuroone Medical Technologies' Return on Sales' 5-year high stood at 0.55% during Q4 2024, with a 5-year trough of 131.25% in Q1 2021.
  • Moreover, its 5-year median value for Return on Sales was 6.53% (2023), whereas its average is 29.45%.
  • Per our database at Business Quant, Neuroone Medical Technologies' Return on Sales crashed by -557700bps in 2021 and then soared by 806000bps in 2023.
  • Neuroone Medical Technologies' Return on Sales (Quarter) stood at 83.19% in 2021, then surged by 82bps to 15.12% in 2022, then skyrocketed by 77bps to 3.42% in 2023, then skyrocketed by 116bps to 0.55% in 2024, then crashed by -191bps to 0.5% in 2025.
  • Its last three reported values are 0.5% in Q4 2025, 0.59% for Q3 2025, and 0.88% during Q2 2025.